glutathione disulfide has been researched along with dexrazoxane in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Haskova, P; Jansova, H; Machacek, M; Mackova, E; Simunek, T; Sterba, M; Tichotova, L; Vavrova, A | 1 |
2 other study(ies) available for glutathione disulfide and dexrazoxane
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Catalytic inhibitors of topoisomerase II differently modulate the toxicity of anthracyclines in cardiac and cancer cells.
Topics: Animals; Animals, Newborn; Anthracyclines; Biocatalysis; Caspases; Cell Cycle; Cell Proliferation; Cell Survival; Cells, Cultured; Daunorubicin; Dexrazoxane; DNA Topoisomerases, Type II; Doxorubicin; Drug Interactions; Flow Cytometry; Glutathione; Glutathione Disulfide; HL-60 Cells; Humans; Myocytes, Cardiac; Piperazines; Rats; Rats, Wistar; Thiobarbiturates; Topoisomerase II Inhibitors | 2013 |